People living with retinitis pigmentosa (RP) may one day benefit from a new drug being trialled in Australia.
The world’s first Myopia Action Month is taking place this month, with the aim to turn myopia awareness into action. A concept developed by
Eyetelligence, an Australian-based leading innovator in AI-powered healthcare solutions, will showcase its cutting-edge eye screening software at O=MEGA23 in Melbourne from 7 – 9
Kodiak Sciences has scrapped its attempt at making an anti-VEFG candidate to rival Eylea.
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
